These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2421085)

  • 1. [Correlations of immune system indices in patients with myelomatosis].
    Konstantinova NA; Cheredeev AN; Kilikovskiĭ VV; Golenkov AK
    Lab Delo; 1986; (3):157-9. PubMed ID: 2421085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of tumor necrosis factor-alpha and red cell immunity state in multiple myeloma].
    Huang Z; Chen S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):563-5. PubMed ID: 11263337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mitogen-induced cellular cytotoxicity by serum from patients with multiple myeloma.
    Papadaki H; Konsolas J; Chatzivassili A; Katrinakis G; Foudoulakis A; Markidou F; Alexandrakis M; Kyriakou D; Eliopoulos GD
    Haematologia (Budap); 1997; 28(3):123-30. PubMed ID: 9283912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the function of monocytes from patients with multiple myeloma. IV. Effects of the monocytes on the function of lymphocytes].
    Funato T; Watanabe Y; Hayashi M; Koide A; Hirasawa Y; Ohtani H; Saito M
    Rinsho Byori; 1983 Oct; 31(10):1135-9. PubMed ID: 6674586
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodeficiency and immunotherapy in multiple myeloma.
    Pratt G; Goodyear O; Moss P
    Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of the immune system in multiple myeloma during polychemotherapy].
    Golenkov AK; Cheredeev AN; Zlatkina AR; Konstantinpva NA; Mattes KH
    Gematol Transfuziol; 1987 Jun; 32(6):9-13. PubMed ID: 3623063
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunodeficiency states.
    Lessof MH
    Proc R Soc Med; 1974 Jun; 67(6 Pt 2):530-6. PubMed ID: 4368789
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma.
    Vacca A; Campobasso N; Iodice G; Ronco M; Dammacco F
    Chemioterapia; 1985 Apr; 4(2):147-55. PubMed ID: 3924421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurring pneumonia revealing multiple myeloma. Immunologic study].
    Worms R; Cayeux P
    Bull Acad Natl Med; 1969; 153(19):328-37. PubMed ID: 4901562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of immune status indices in workers employed in production of harmful substances].
    Vorob'eva AM; Balannik ZT; Kuzovkova SD; Pavlovskaia MN; Smitiuk LA
    Gig Sanit; 1993 May; (5):21-2. PubMed ID: 8063153
    [No Abstract]   [Full Text] [Related]  

  • 12. [An approach of immunology. Immunological abnormalities in multiple myeloma].
    Funato T; Ohtani H
    Rinsho Byori; 1984 Aug; 32(8):828-34. PubMed ID: 6502981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of indices of immune reactivity of the body in patients with chronic cerebral arachnoiditis].
    Golovchenko IuI; Makarova TT
    Vrach Delo; 1988 May; (5):78-80. PubMed ID: 3420880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoreactive parathyroid hormone in serum in myelomatosis. A descriptive clinical study].
    Hansen OP; Christensen MS; Birgens HS; Wantzin PS
    Ugeskr Laeger; 1981 Jul; 143(30):1908-11. PubMed ID: 7303208
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the immunity indices of women in occupational contact with synthetic estrogens].
    Rotkina IE; Mitrofanov NA
    Gig Tr Prof Zabol; 1985 Aug; (8):53-4. PubMed ID: 4054659
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indices of immune reactivity in patients with chronic pneumonia].
    Babenko TF; Skuratovskiĭ MF; Kurkova RA; Storozhenko VV; Skidonenko VG
    Vrach Delo; 1983 Jan; (1):99-102. PubMed ID: 6603066
    [No Abstract]   [Full Text] [Related]  

  • 17. 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.
    Yamada H; Yamada A; Hollander VP
    J Immunol; 1970 Jan; 104(1):251-5. PubMed ID: 4904002
    [No Abstract]   [Full Text] [Related]  

  • 18. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
    Nilsson K; Bennich H; Johansson SG; Pontén J
    Clin Exp Immunol; 1970 Oct; 7(4):477-89. PubMed ID: 4097745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indices of cellular and humoral immunity in patients with melanobalstoma].
    Korosteleva TA; Ryshkov VI; Veresova OV; Potapenkova LS; Skachkov AP
    Vopr Onkol; 1982; 28(9):19-23. PubMed ID: 7123877
    [No Abstract]   [Full Text] [Related]  

  • 20. Nature of antigen recognition site in cellular immunity.
    Warner NL
    Transplant Proc; 1971 Mar; 3(1):848-51. PubMed ID: 4106344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.